| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.1M | +167.0% |
| R&D Expense | $904K | -57.9% |
| SG&A Expense | $9.8M | +7.5% |
| Operating Income | -$22.3M | -0.9% |
| Interest Expense | $291K | -8.0% |
| Pre-tax Income | -$22.2M | +0.7% |
| Income Tax | $0 | — |
| Net Income | -$22.2M | +0.7% |
| EPS (Diluted) | -$0.31 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $101.6M | +14.9% |
| Short-term Investments | $101.8M | +0.0% |
| Inventory | $2.3M | +80.7% |
| Current Assets | $106.0M | -45.1% |
| Total Assets | $213.8M | -6.4% |
| Current Liabilities | $15.4M | +162.2% |
| Long-term Debt | $8.7M | -5.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.0M | -2.6% |
| Capital Expenditures | $67.5M | +1090.3% |
| Investing Cash Flow | $34.4M | +131.9% |
| Financing Cash Flow | -$162K | -100.1% |
| Free Cash Flow | -$88.5M | -238.5% |
| +3.1% |
| Total Liabilities |
| $21.9M |
| +49.8% |
| Stockholders' Equity | $191.9M | -10.2% |